2-Amino-6-bromo-1,8-naphthyridine, 95.0%, 1g

Thieno[3,2-b]pyridin-7-ol, 95.0%, 1g

Alcool benzilico, minimo 98%, per sintesi, 2,5 L, confezione in vetro

1,3-Oxathiolane-2-carboxylic acid, 5-(4-amino-5-fluoro-2-oxo-1(2H)-pyrimidinyl)-, (1R,2S,5R)-5-methyl-2-(1-methylethyl)cyclohexyl ester, (2S,5R)-, 100g

3-(1H-1,2,3-Triazol-1-yl)propanoic acid hydrochloride, 97%, 100mg

3,5-Dimethylpyrrole-2-carboxylic acid, 95.0%, 10g

TAZEMETOSTAT, 98%, 250mg

3-Boc-Amino-3-(3-pyridyl)-propionic acid, 95.0%, 1g

7-Bromoisoquinoline>96.0%(GC)1g

2-(2-Methyl-1H-indol-3-ylsulfanyl)-ethylamine, 95.0%, 1g

(S)-3-METHYL-PENTANOIC ACID, 97.0%, 1g

Ethyl 3-amino-2,2-dimethylpropanoate, 95.0%, 250mg

3,4,5-Trifluorobenzylamine, 97.0%, 10g